Investment Summary

Edgewater Capital Partners Invests In Comprehensive Blood & Cancer Center

On May 27, 2025, private equity firm Edgewater Capital Partners invested in life science company Comprehensive Blood & Cancer Center

Investment Highlights
  • This is Edgewater Capital Partners’ 4th transaction in the Life Science sector.
  • This is Edgewater Capital Partners’ 30th transaction in the United States.
  • This is Edgewater Capital Partners’ 5th transaction in California.

Investment Summary

Date 2025-05-27
Target Comprehensive Blood & Cancer Center
Sector Life Science
Investor(s) Edgewater Capital Partners
Deal Type Growth Capital
Advisor(s) Edgemont Capital Partners (Financial)
Stradling Yocca Carlson & Rauth (Legal)

Target

Comprehensive Blood & Cancer Center

Bakersfield, California, United States
Comprehensive Blood & Cancer Center is a multi-national clinical contract research organization with deep experience in designing and managing clinical trials across a range of therapeutic areas, including oncology, CNS, and ophthalmology. Comprehensive Blood & Cancer Center is based in Bakersfield, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Edgewater Capital Partners

Cleveland, Ohio, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1982
Size Middle-Market
Type Sector Focused
DESCRIPTION

Edgewater Capital Partners is a private equity firm focused on acquiring established, lower middle-market companies. Prospective investment situations include corporate divestitures, management buyouts, and family business liquidity. The Firm's industry preferences include highly-engineered manufacturing, specialty chemicals, specialty Industrials, Life Science. Edgewater Capital Partners was formed in 1982 and is based in Cleveland, Ohio.


DEAL STATS #
Overall 31 of 31
Sector: Life Science M&A 4 of 4
Type: Growth Capital M&A Deals 4 of 4
State: California M&A 5 of 5
Country: United States M&A 30 of 30
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-13 Pure Wafer

San Jose, California, United States

Pure Wafer is a provider of silicon wafer reclaim services and supplies virgin silicon wafers, specialty thin film deposition products, and silicon parts services. Pure Wafer was founded in 2008 and is based in San Jose, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-10-14 Luxium Solutions

Hiram, Ohio, United States

Luxium Solutions is a manufacturer of single scintillation crystals for radiation detection applications, as well as sapphire and garnet substrates for photonics and power electronics applications. Luxium Solutions was founded in 1969 and is based in Hiram, Ohio.

Sell -